Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Parsons

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Clinical Drug Investigation|June 28, 2019
Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral NeuropathyJoe Alexander, Roger A Edwards, Marina Brodsky, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 24, 2014
Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgiaJeffrey J Ellis, Alesia B Sadosky, Laura L Ten Eyck, et al.
Pain Medicine (Malden, Mass.)|July 22, 2014
Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluationCaroline Schaefer, Rachael Mann, Alesia Sadosky, et al.
Journal of Medical Economics|March 29, 2014
Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional surveyCaroline Schaefer, Rachael Mann, Alesia Sadosky, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 8, 2014
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational StudyCaroline Schaefer, Alesia Sadosky, Rachael Mann, et al.
The Clinical Journal of Pain|January 8, 2015
Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on WalkingCynthia Huffman, Brett R Stacey, Michael Tuchman, et al.
BMC Health Services Research|April 19, 2015
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetineJeffrey J Ellis, Alesia B Sadosky, Laura L Ten Eyck, et al.
Journal of Pain Research|July 5, 2013
Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United StatesBruce Parsons, Caroline Schaefer, Rachael Mann, et al.
Advances in Therapy|May 15, 2017
Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician SurveysRayaz A Malik, Emre Aldinc, Siew-Pheng Chan, et al.
Journal of Pain Research|January 8, 2015
Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical modelsNeil K Singla, Jacques E Chelly, David R Lionberger, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical Drug Investigation|June 28, 2019
Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral NeuropathyJoe Alexander, Roger A Edwards, Marina Brodsky, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 24, 2014
Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgiaJeffrey J Ellis, Alesia B Sadosky, Laura L Ten Eyck, et al.
Pain Medicine (Malden, Mass.)|July 22, 2014
Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluationCaroline Schaefer, Rachael Mann, Alesia Sadosky, et al.
Journal of Medical Economics|March 29, 2014
Health status, function, productivity, and costs among individuals with idiopathic painful peripheral neuropathy with small fiber involvement in the United States: results from a retrospective chart review and cross-sectional surveyCaroline Schaefer, Rachael Mann, Alesia Sadosky, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 8, 2014
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational StudyCaroline Schaefer, Alesia Sadosky, Rachael Mann, et al.
The Clinical Journal of Pain|January 8, 2015
Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on WalkingCynthia Huffman, Brett R Stacey, Michael Tuchman, et al.
BMC Health Services Research|April 19, 2015
A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetineJeffrey J Ellis, Alesia B Sadosky, Laura L Ten Eyck, et al.
Journal of Pain Research|July 5, 2013
Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United StatesBruce Parsons, Caroline Schaefer, Rachael Mann, et al.
Advances in Therapy|May 15, 2017
Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician SurveysRayaz A Malik, Emre Aldinc, Siew-Pheng Chan, et al.
Journal of Pain Research|January 8, 2015
Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical modelsNeil K Singla, Jacques E Chelly, David R Lionberger, et al.
Pageof 8